Dermatology News CME

• FDA Safety Changes: Prevpac, Arava, Treanda CME/CE The FDA has approved safety labeling revisions for a prepackaged regimen of lansoprazole, amoxicillin, and clarithromycin tablets; leflunomide tablets; and bendamustine HCl intravenous infusion.
  Medscape Medical News CME, July 2009
• Psoriasis Associated With All Vascular Disease CME As well as being an independent risk factor for cardiovascular disease, psoriasis is also associated with an increased risk of cerebrovascular disease and peripheral arterial disease, a new case-control study has shown.
  Heartwire CME, June 2009
• Hydroxychloroquine Use May Be Safe in Systemic Lupus Erythematosus CME A systematic review suggests that hydroxychloroquine should be given to most patients with systemic lupus erythematosus during the whole course of the disease and should be continued during pregnancy.
  Medscape Medical News CME, June 2009
• Home Phototherapy Is as Safe, Effective as Outpatient Therapy for Treating Psoriasis CME In a randomized controlled trial, ultraviolet B phototherapy given at home or in an outpatient setting were equally safe and effective in the treatment of psoriasis, both clinically and for quality of life.
  Medscape Medical News, May 2009
• FDA Safety Changes: Visicol, OsmoPrep, DiaBeta, Raptiva CME/CE The FDA has approved safety labeling revisions for sodium phosphate monobasic monohydrate and sodium phosphate dibasic anhydrous tablets (Visicol and OsmoPrep), glyburide tablets (DiaBeta), and efalizumab subcutaneous injection (Raptiva).
  Medscape Medical News, May 2009
• Psoriasis Linked to Increased Risk for Diabetes and Hypertension CME/CE In a prospective study of US female nurses, psoriasis was independently associated with an increased risk for diabetes and hypertension.
  Medscape Medical News, April 2009
• Factors Identified Linked to Early Detection of Melanoma in Older Men CME Physician-detected melanoma in older men is more likely to be thinner, more treatable, located on the back, and associated with a history of atypical nevi.
  Medscape Medical News, April 2009
• FDA Approvals: Coartem and Benzyl Alcohol Lotion CME/CE The FDA has approved artemether-lumefantrine tablets (Coartem) and benzyl alcohol 5% lotion.
  Medscape Medical News, April 2009
• FDA Safety Changes: Tracleer, Nexium, Nexium IV, Tygacil CME/CE The FDA has approved revisions to the safety labeling for bosentan tablets, esomeprazole injection, esomeprazole magnesium delayed-release capsules and oral suspension, and tigecycline injection.
  Medscape Medical News, April 2009
• Combing Wet Hair May Be Best to Identify Active Head Lice Infestation CME A study shows that combing through a child's wet hair may be more accurate than visual inspection to identify active head lice infestation.
  Medscape Medical News, March 2009
• Ingrown Toenail Management Reviewed CME A review discusses risk factors, conservative therapy, and surgical approaches regarding management of the ingrown toenail in primary care.
  Medscape Medical News, February 2009
• TNF Inhibitors May Increase Shingles Risk CME Drugs that inhibit tumor necrosis factor-alpha have already been associated with serious infectious complications, and investigators say shingles should now be added to the list.
  Medscape Medical News, February 2009
• FDA Approves Calcitriol Ointment for Psoriasis CME The FDA recently approved calcitriol ointment 3 ìg/g (Vectical, Galderma Laboratories, LP), a first-of-its-kind, topical ointment to treat psoriasis.
  Medscape Medical News, February 2009
• FDA Safety Changes: Promethazine HCl and Codeine Oral Solution, Ranexa, Ethyol CME The FDA has approved revisions to the safety labeling for promethazine HCl and codeine phosphate oral solution, ranolazine extended-release tablets, and amifostine injection.
  Medscape Medical News, February 2009
• Current Evidence Insufficient to Support Skin Cancer Screening by Primary Care Clinicians CME/CE The US Preventive Services Task Force states that the balance of benefits and harms of screening for skin cancer by primary care clinicians or by patient skin self-examination is undetermined.
  Medscape Medical News, February 2009
• Primary Care Management of Skin Pigmentation Disorders Reviewed CME A review provides practice recommendations for primary care clinicians to diagnose and treat skin pigmentation disorders.
  Medscape Medical News, January 2009
• Use of Topical Corticosteroids for Dermatologic Conditions Reviewed CME/CE A review discusses the best practices for choosing topical corticosteroids for patients with various dermatologic conditions.
  Medscape Medical News, January 2009
• FDA Safety Changes: Apidra, Ontak, Raptiva CME The FDA has approved revisions to the safety labeling for insulin glulisine [rDNA origin] injection (Apidra), denileukin diftitox (Ontak), and efalizumab (Raptiva).
  Medscape Medical News, January 2009
• FDA Safety Changes: Celexa, Erbitux, ACE Inhibitors CME The FDA has approved revisions to the safety labeling for citalopram HBr tablets and oral solution, cetuximab intravenous infusion, and certain angiotensin-converting enzyme inhibitors.
  Medscape Medical News, December 2008
• FDA Approvals: Premarin, Norditropin, Acanya CME The FDA has approved a new indication for a conjugated estrogens topical vaginal cream, an expanded indication for somatropin injection, and clindamycin phosphate plus benzoyl peroxide topical gel.
  Medscape Medical News, November 2008